Symptom Information: Sort according to HPO 

1
(HPO:0000252) Microcephaly 832 / 7739
2
(HPO:0000577) Exotropia 43 / 7739
3
(HPO:0001250) Seizures 1245 / 7739
4
(HPO:0001252) Muscular hypotonia 990 / 7739
5
(HPO:0001324) Muscle weakness 859 / 7739
6
(HPO:0001254) Lethargy 104 / 7739
7
(HPO:0001263) Global developmental delay 853 / 7739
8
(HPO:0001270) Motor delay 322 / 7739
9
(HPO:0001943) Hypoglycemia 131 / 7739
10
(HPO:0002045) Hypothermia 27 / 7739
11
(HPO:0003700) Generalized amyotrophy 39 / 7739
12
(HPO:0005949) Apneic episodes in infancy 5 / 7739
13
(HPO:0000486) Strabismus 576 / 7739
14
(HPO:0008947) Infantile muscular hypotonia 482 / 7739
15
(HPO:0010547) Muscle flaccidity 466 / 7739
16
(OMIM) Global developmental delay if untreated 1 / 7739
17
(OMIM) Increased urinary 2-methylbutyrylglycine 1 / 7739
18
(OMIM) Increased plasma 2-methylbutyrylcarnitine 1 / 7739
19
(OMIM) Decreased short/branched-chain acyl-CoA dehydrogenase protein levels and enzyme activity 1 / 7739
20
(HPO:0000007) Autosomal recessive inheritance 2538 / 7739
21
(HPO:0003593) Infantile onset 249 / 7739